• WellDoc's disruptive innovation in healthcare and mHealth uses mobile technology to transform the treatment of chronic disease.

    WellDoc's disruptive innovation in healthcare and mHealth uses mobile technology to transform the treatment of chronic disease.
  • Forbes Disruptive Innovation Article
  • Fast Company mHealth Coverage
  • A NASDAQ Health Innovations Company
  • CNN mHealth Coverage
  • Disruptive Innovation Examples in The New York Times

Strategic Partners

Digital Health Company of Firsts Revolution

WellDoc created digital health solutions long before smart phones were invented. We are the first digital health company to conduct randomized clinical trials that demonstrated significant clinical outcomes, which were published in peer-reviewed journals, and the first digital health company built on a life science business model.

Our Suite of Products

Our digital health solutions are changing the face of chronic disease management, reducing costs, improving clinical outcomes, and creating hope and change for individuals living with chronic diseases. Our product offerings are currently focused on type 2 diabetes and WellDoc is pursuing solution development in other therapeutic areas.

  • Disruptive Innovations BlueStar

    The First of Its Kind

    We have been successfully commercializing BlueStar, the first FDA cleared mobile prescription therapy for type 2 diabetes in mHealth.

  • Advances in Medical Technology

    Experts in Data Science

    WellDoc's data science capabilties include predictive analytics, population health analysis and self-management behavioral science.

mHealth Evidence

Clinical Evidence

We are contributing disruptive healthcare innovations to the scientific evidence of mHealth including efficacy, behavioral frameworks, informatics and data analytics.

Stay Connected